Skip to content

Comparison of Prophylactic Use of Tramadol Versus Ketamine for Prevention of Post Spinal Anesthesia Shivering

Comparison of Prophylactic Use of Tramadol Versus Ketamine for Prevention of Post Spinal Anesthesia Shivering

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07043049
Acronym
KETRA4PSAS
Enrollment
92
Registered
2025-06-29
Start date
2022-06-29
Completion date
2022-12-31
Last updated
2025-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shivering

Keywords

Shivering, Spinal Anesthesia

Brief summary

The goal of this clinical trial is to compare the effectiveness of tramadol versus ketamine in preventing shivering after spinal anesthesia in adult patients (ages 20-65) undergoing elective lower abdominal or inguinoscrotal surgeries. The main questions it aims to answer are: * Does prophylactic intravenous tramadol reduce the incidence and severity of shivering more effectively than ketamine after spinal anesthesia? * Are there differences in side effects, such as sedation or nausea, between tramadol and ketamine? Researchers will compare the tramadol group to the ketamine group to see which drug is more effective and safer for shivering prevention. Participants will: * Be randomly assigned to receive either tramadol (1 mg/kg) or ketamine (0.5 mg/kg) five minutes after spinal anesthesia. * Have their shivering severity assessed at 15, 30, 45, and 60 minutes using a standardized scale. * Be monitored for sedation, nausea, and other possible side effects.

Interventions

DRUGTramadol

Tramadol 1 mg/kg IV given 5 minutes after spinal anesthesia for prevention of post-anesthesia shivering

DRUGKetamine

Ketamine 0.5 mg/kg IV administered 5 minutes after spinal anesthesia for prevention of post-anesthesia shivering.

Sponsors

Syed Muhammad Abbas
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Caregiver, Investigator)

Masking description

The study medications were prepared in identical syringes by an independent anesthesiologist not involved in patient care to maintain blinding. Both the anesthesia providers and outcome assessors were blinded to group allocation throughout the study.

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

1. Patients aged 20 to 65 years, 2. American Society of Anesthesiologists (ASA) Physical Status I or II, and 3. Scheduled for elective lower abdominal or inguinoscrotal surgeries 4. Under spinal anesthesia were included

Exclusion criteria

1. Thyroid or neuromuscular disorders, 2. Pregnant 3. History of chronic sedative or narcotic use, 4. Requiring intraoperative blood transfusion 5. Had a baseline body temperature greater than 38°C or less than 36°C, 6. Undergoing transurethral resection of the prostate (TURP).

Design outcomes

Primary

MeasureTime frameDescription
Incidence and Severity of Post-Spinal Anesthesia ShiveringUp to 60 minutes post spinal anesthesiaThe incidence and severity of shivering will be assessed using the Bedside Shivering Assessment Scale (BSAS) at 15, 30, 45, and 60 minutes following the administration of spinal anesthesia. BSAS Grading: * 0 = No shivering * 1 = Piloerection or peripheral vasoconstriction without visible shivering * 2 = Visible muscular activity confined to one muscle group * 3 = Gross muscular activity involving the entire body

Secondary

MeasureTime frameDescription
Sedation ScoreUp to 60 minutes post spinal anesthesiaSedation will be measured using the Ramsay Sedation Scale (RSS) at 15, 30, 45, and 60 minutes post spinal anesthesia. RSS scores range from 1 (anxious, agitated) to 6 (no response). Median and interquartile ranges will be calculated for each group.
Incidence of Postoperative Nausea and Vomiting (PONV)Up to 60 minutes post spinal anesthesiaPONV will be assessed using the PONV Impact Scale at 15, 30, 45, and 60 minutes post spinal anesthesia. Presence or absence will be recorded at each time point.

Other

MeasureTime frameDescription
Rescue Analgesic UseWithin 60 minutes post spinal anesthesiaAdministration of rescue pethidine (0.35 mg/kg IV) for Grade 3 shivering lasting more than 15 minutes will be recorded.
Adverse Events MonitoringIntraoperative and up to 60 minutes post spinal anesthesiaIncidence of other side effects including hypotension, hypertension, hallucinations, and excessive sedation will be actively monitored and recorded intraoperatively and up to 60 minutes after spinal anesthesia.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026